Operating Segments

6 Months Ended

Jun. 30, 2022

Operating Segments

Operating Segments

Note 10. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended
	June 30,
	2022		2021
Revenues
Specialized BioTherapeutics	$	—	$	—
Public Health Solutions		228,640		214,824
Total	$	228,640	$	214,824
Loss from Operations
Specialized BioTherapeutics	$	(2,000,350)	$	(1,720,566)
Public Health Solutions		(1,002)		(231,954)
Corporate		(1,393,944)		(1,036,139)
Total	$	(3,395,296)	$	(2,988,659)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	2,783	$	1,862
Public Health Solutions		463		311
Corporate		5,266		6,667
Total	$	8,512	$	8,840
Other (Expense) Income, Net
Specialized BioTherapeutics	$	68,509	$	41,001
Corporate		(214,908)		185,848
Total	$	(146,399)	$	226,849
Share-Based Compensation
Specialized BioTherapeutics	$	28,343	$	28,731
Public Health Solutions		1,054		7,189
Corporate		42,273		44,701
Total	$	71,670	$	80,621

	Six Months Ended
	June 30,
	2022		2021
Revenues
Specialized BioTherapeutics	$	—	$	—
Public Health Solutions		416,703		362,417
Total	$	416,703	$	362,417
Loss from Operations
Specialized BioTherapeutics	$	(3,540,078)	$	(2,832,974)
Public Health Solutions		(121,623)		(362,735)
Corporate		(3,925,981)		(2,026,557)
Total	$	(7,587,682)	$	(5,222,266)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	5,397	$	3,761
Public Health Solutions		899		627
Corporate		10,448		13,351
Total	$	16,744	$	17,739
Other (Expense) Income, Net
Specialized BioTherapeutics	$	123,588	$	125,635
Corporate		(426,622)		(27,657)
Total	$	(303,034)	$	97,978
Share-Based Compensation
Specialized BioTherapeutics	$	56,847	$	58,310
Public Health Solutions		2,108		13,484
Corporate		90,986		103,632
Total	$	149,941	$	175,426

	As of		As of
	June 30,		December 31,
	2022		2021
Identifiable Assets
Specialized BioTherapeutics	$	167,524	$	128,645
Public Health Solutions		330,545		146,296
Corporate		20,814,385		26,594,986
Total	$	21,312,454	$	26,869,927